
|Articles|September 23, 2015
Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies
Author(s)Shaji Kumar
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
Advertisement
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Breaking Down Advancements in Prostate Cancer Care
2
FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer
3
When One Blood Draw Could Tell More: A Look at the Cancerguard Test
4
Shared Loss Leads to Lifelong Friendship in Rare Cancer Caregiving
5





